Target intelligence / Profile preview

Bacterial surface antigen of Campylobacter jejuni

Molecular classification
Other
01

Overview

Bacterial surface antigens of Campylobacter jejuni include a diverse group of outer membrane proteins and glycoproteins, such as the major outer membrane protein (MOMP), PEB3, JlpA, and others, as well as surface-exposed lipooligosaccharides and polysaccharides[1][4]. These antigens are critical for the bacterium’s ability to attach to and invade host epithelial cells, facilitate colonization, and evade host immune defenses by undergoing structural variation in response to environmental pressures[1][4]. Immune responses to these antigens involve the production of antibodies, which can provide protection but may also, through molecular mimicry, contribute to the development of Guillain-Barré syndrome[2]. Surface antigens are under active investigation as vaccine targets, although high antigenic diversity and immune evasion limit efficacy to date[1][4].

Other names
Campylobacter jejuni outer membrane antigenCampylobacter jejuni surface-exposed proteinC. jejuni antigen
02

Mechanism of action

Vaccination (experimental; immune system targeting through antibody-mediated neutralization or opsonization)

03

Biological functions

Immune responsePathogen-host cell adhesionImmune evasion
04

Disease associations

InfectionAutoimmune complication (Guillain-Barré syndrome)
05

Safety considerations

Antigenic variability complicates vaccine developmentrisk of triggering autoimmune responses through molecular mimicry
06

Interacting drugs

None (no approved drugs directly target these antigens as a primary mechanism)
07

Biomarkers

Anti-Campylobacter antibody titers (as marker of infection or previous exposure)

Beyond the preview

Go deeper on Bacterial surface antigen of Campylobacter jejuni.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial surface antigen of Campylobacter jejuni.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call